Vaginal Mesh in Pelvic Reconstructive Surgery: Controversies, Current Use, and Complications.

Published

Journal Article (Review)

In 2001, the Food and Drug Administration approved the first surgical mesh product specifically designed for the surgical repair of pelvic organ prolapse and between 2004 and 2008, the use of vaginal mesh in gynecologic surgery was at its peak. Unfortunately, the rise in transvaginal mesh use was accompanied by a surge of adverse events and mesh-related complications. As a result, the Food and Drug Administration put forth several efforts to regulate the manufacturing of vaginal mesh products. These notifications have been supported by several gynecologic societies, and recommendations now exist not only on the placement of mesh and patient selection, but also on the evaluation and management of mesh-related complications. In addition, data on outcomes following management of these complications are now emerging.

Full Text

Cited Authors

  • Unger, CA; Barber, MD

Published Date

  • December 2015

Published In

Volume / Issue

  • 58 / 4

Start / End Page

  • 740 - 753

PubMed ID

  • 26512439

Pubmed Central ID

  • 26512439

Electronic International Standard Serial Number (EISSN)

  • 1532-5520

Digital Object Identifier (DOI)

  • 10.1097/GRF.0000000000000148

Language

  • eng

Conference Location

  • United States